Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback